Simplifying the Complex Compliance Monitoring Requirements

Live Webinar

Monday, Aug 22, 2022 at 1:00 PM EDT

Overview

Continually evolving and expanding rules and regulations amid the pressures of the pandemic have impacted life sciences companies, making it challenging for compliance professionals to meet the modern compliance demands primarily due to the complexities involved in the process.

Ever-changing compliance requirement sand new tensions threaten the overall life science compliance exposing an organization to the risk of non-compliant.

Today, mostcompliance leaders believe that compliance monitoring challenges have become complex, and this perspective needs to change. This webinar aims to enable life sciencesand compliance leaders, to rethink the complex compliance monitoring.

<span data-metadata=""><span data-buffer="">Discussion Topics

Overview of an effective compliance program from the government perspective
What are the deficiencies in company monitoring programs
Recommendations for companies to enhance their monitoring programs

SPEAKERS

Jim Dawson

Chief Compliance Officer | Qordata

Jim Dawson is dynamic and enthusiastic compliance professional with more than 13 years of comprehensive experience leading billion-dollar companies’ corporate compliance programs in the biopharmaceutical industries.

As a skilled communicator with a team-oriented approach, he’s been able to build collaborative relationships across multi-disciplinary business units, executive/senior leadership, and stakeholders at all organizational levels.

Mohammad Ovais

Founder & CEO | Qordata

Mohammad Ovais is the Founder & CEO of qordata and has spent a decade building analytical solutions and applications for Fortune 1000 companies. Before this, he served as the Managing Partner/Co-Founder at Streebo.

With a Bachelor in Computer Science from Rice University and EMP from MIT, he serves on the board of Entrepreneur Organization as Strategic Alliances Chair.

Bill Sarraille

Senior Partner | Sidley Austin

Bill Sarrailleis a senior member of the Healthcare Practice Group and a nationally-recognized lawyer in healthcare law. He also serves as a Global Coordinator for Healthcare in the Privacy, Data Security & Information Law Practice.

Mr. Sarraille concentrates on a variety of healthcare matters, including Medicare and Medicaid reimbursement, coverage and coding, pharmaceutical price reporting, issues related to the marketing and promotion of pharmaceuticals and medical devices, internal investigations, clinical research issues, Stark and Anti-Kickback Law analyses, Medicare and Medicaid audits, healthcare acquisitions and more.

Who should attend?

Mid-level to Chief Compliance Officers at drug or medical device manufacturing companies and legal teams working in the life sciences compliance industry.